FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
healthday2d
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...
The New York Times20d
Joao Lucas Reis da Silva, the first out gay active professional male tennis player, was just posting a selfie
“I love you so much,” he wrote. The post made him a trailblazer — the first out gay active professional male tennis player — but he was just wishing his partner a happy birthday. Advertise ...
Medindia25d
Pelvital Launches Next-Generation FDA-Cleared Flyte® System, Treating All Severities of Stress Urinary Incontinence
"Flyte has already transformed the lives of thousands of women with stress urinary incontinence ... is optional and is not required for the system's operation. Flyte's unique mechanotherapy ...
UroToday27d
Two-year efficacy and safety outcomes of the pivotal OASIS Study using the Revi® System for treatment of urgency urinary incontinence.
The BlueWind Medical Device, Revi®, is a novel implantable tibial neuromodulation system powered by an external, battery-operated wearable that facilitates individually tailored stimulation to provide ...